“…A key limitation in the use of PFCs is their fluorophilicity, which renders them largely insoluble and potentially toxic in aqueous environments. Emulsification with lipid surfactants has typically been the solution [9,10]. However, these emulsions often proved unstable and difficult to use, for example, the FDA-approved blood substitute Fluosol-DA (Green Cross Corp., Osaka, Japan), must be stored frozen and the emulsion components mixed immediately before use.…”